Farm Comunitarios. 2023 Oct 16;15(4):13-25. doi: 10.33620/FC.2173-9218.(2023).27

May Measurement Month 2019: Screening Analysis In Spanish Community Pharmacies and Detection of Masked Hypertension

Mera-Gallego I1, Tous i Trepat S2, Prats-Mas R3, Molinero A4, Fornos-Pérez JA5, Andrés-Rodríguez NF6
1. Member of the SEFAC Diabetes group. Community pharmacy in Maella (Zaragoza) 2. Member of the HTA and RV group at SEFAC. Community pharmacist in Igualada (Barcelona) 3. Doctor of Pharmacy. Community pharmacy in Denia (Alicante) 4. Doctor of Pharmacy. Member of the HTA group and RV from SEFAC. Associate Professor UAH. Community pharmacy in Fuenlabrada (Madrid) 5. Doctor of Pharmacy. Member of the SEFAC Diabetes group. USC Associate Professor. Community pharmacist in Cangas do Morrazo (Pontevedra) 6. Doctor of Pharmacy. Member of the SEFAC Diabetes group
Mera-Gallego I, Tous S, Prats-Mas R, Molinero A, Fornos-Pérez JA, Andrés-Rodríguez NF. May Measurement Month 2019: Screening Analysis In Spanish Community Pharmacies and Detection of Masked Hypertension. Farm Comunitarios. 2023 Oct 16;15(4):13-25. doi: 10.33620/FC.2173-9218.(2023).27
Abstract : 

Aim: To know within the scope of the May Measurement Month (MMM) project, the blood pressure (BP) situation in the Spanish population, disseminate the importance of its periodic measurement and estimate the prevalence of masked hypertension (MH).

Methods: Transversal descriptive study in Spanish community pharmacies during May 2019. Subjects: adult users who agreed to take part.

Variables: systolic blood pressure (SBP), diastolic blood pressure (DBP) in millimetres of mercury (mmHg), heart rate (HR) in beats per minute (bpm).

Subjects with BP ≥130/85 and <149/90 were offered the possibility of home blood pressure monitor- ing (HBPM) to confirm MH.

Results: A total of 3402 valid records performed by 491 pharmacists. In all 61.9% women, mean age

56.6 years. A total of 143 (4.2%) had never measured BP and 918 (27.0%) had not measured BP in the last year; 1047 were taking anti-hypertensives, of whom 45.7% had high BP.

A total of 780 (22.9%) subjects had high BP values; both, 252 (7.4%). mSBP and mDBP was 125.0 mmHg and 76.5 mmHg, respectively; higher in men (P<0.001). mHR was 72.6 bpm.

A direct relationship was detected between SBP and DBP and BMI (P<0.0001). mSBP and mHR were higher in smokers (P<0.0001). In diabetic patients, SBP, DBP and HR were greater.

A total of 61 subjects with suspected MH agreed to undergo HBPM. A total of 25 (40.1%) resulted in BP ≥135/85 mmHg.

Conclusions: Almost a quarter of subjects had BP ≥140/90 mmHg. The risk factors most closely related to high BP were overweight, diabetes and age; 40% of suspected cases of MH were confirmed by means of HBPM.

Article download link: 

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Manual for authors

Journal Information